PT1575483E - Bactérias gram negativas atenuadas - Google Patents

Bactérias gram negativas atenuadas Download PDF

Info

Publication number
PT1575483E
PT1575483E PT03719577T PT03719577T PT1575483E PT 1575483 E PT1575483 E PT 1575483E PT 03719577 T PT03719577 T PT 03719577T PT 03719577 T PT03719577 T PT 03719577T PT 1575483 E PT1575483 E PT 1575483E
Authority
PT
Portugal
Prior art keywords
gram negative
negative bacteria
bacterium
attenuated gram
mutant
Prior art date
Application number
PT03719577T
Other languages
English (en)
Inventor
Jacqueline Elizabeth Shea
Robert Graham Feldman
Helen Rachel Crooke
Sylvain Gabriel Coutebroze
Francois-Xavier Legros
Original Assignee
Merial Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Llc filed Critical Merial Llc
Publication of PT1575483E publication Critical patent/PT1575483E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT03719577T 2002-04-05 2003-04-04 Bactérias gram negativas atenuadas PT1575483E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37028202P 2002-04-05 2002-04-05
US10/406,686 US7449178B2 (en) 2002-04-05 2003-04-03 Attenuated gram negative bacteria

Publications (1)

Publication Number Publication Date
PT1575483E true PT1575483E (pt) 2011-09-08

Family

ID=29254405

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03719577T PT1575483E (pt) 2002-04-05 2003-04-04 Bactérias gram negativas atenuadas

Country Status (15)

Country Link
US (3) US7449178B2 (pt)
EP (1) EP1575483B1 (pt)
JP (1) JP4338528B2 (pt)
KR (1) KR101037566B1 (pt)
CN (2) CN102864090A (pt)
AT (1) ATE518955T1 (pt)
AU (2) AU2003223447C1 (pt)
BR (1) BRPI0309001B1 (pt)
CA (1) CA2481186C (pt)
CO (1) CO5640065A1 (pt)
ES (1) ES2371498T3 (pt)
MX (1) MXPA04009730A (pt)
NZ (1) NZ535993A (pt)
PT (1) PT1575483E (pt)
WO (1) WO2003086277A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69526377T2 (de) * 1994-12-09 2002-11-07 Microscience Ltd Virulenzgene in der VGC2-Region von Salmonella
WO2000014240A2 (en) * 1998-09-04 2000-03-16 Creatogen Aktiengesellschaft Attenuated salmonella sp12 mutants as antigen carriers
GB9910812D0 (en) * 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
EP1350796B1 (en) * 2002-04-05 2009-01-07 Merial Attenuated gram negative bacteria
DE602004003582T2 (de) 2003-07-02 2007-09-20 Biotechnology Research And Development Corp., Peoria Akapsuläre i p. multocida hyae deletionsmutanten
WO2006122586A1 (en) 2004-12-22 2006-11-23 Intervet International B.V. Pasteurella multocida vaccine
US8703153B2 (en) 2008-06-16 2014-04-22 Prokarium Ltd. Salmonella vectored vaccines against Chlamydia and methods of use
US8917497B2 (en) * 2012-07-23 2014-12-23 Knaack Llc Jobsite storage cabinet for housing electronic equipment
EP3062816B1 (en) 2013-11-01 2020-08-05 Boehringer Ingelheim Animal Health USA Inc. Attenuated pasteurella multocida vaccines & methods of making & use thereof
WO2016049917A1 (en) * 2014-09-30 2016-04-07 Bgi Shenzhen Co., Limited Biomarkers for obesity related diseases
TW202219269A (zh) * 2020-09-30 2022-05-16 美國農業部 新型多殺性巴斯德氏菌株及具有ｈｙａＣ與ｎａｎＰ缺失之疫苗
WO2022072431A1 (en) * 2020-09-30 2022-04-07 Zoetis Services Llc Novel pasteurella multocida strains and vaccines having hyac and nanp deletions
CN116144565B (zh) * 2022-12-21 2025-09-26 四川农业大学 减毒多杀性巴氏杆菌及其构建方法和应用
CN117534732B (zh) * 2023-11-03 2024-10-22 湖南中晟全肽生物科技股份有限公司 一种抑制il-12与其受体结合的多肽及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011024A1 (en) * 1992-11-06 1994-05-26 Regents Of The University Of Minnesota Composition protective against p. multocida pasteurellosis infection
US6793927B1 (en) * 1993-12-06 2004-09-21 The United States Of America As Represented By The Secretary Of The Department Of Agriculture Construction of Pasteurella haemolytica vaccines
DE69526377T2 (de) 1994-12-09 2002-11-07 Microscience Ltd Virulenzgene in der VGC2-Region von Salmonella
HU226219B1 (en) * 1996-05-31 2008-06-30 Intervet Int Bv Live attenuated rtx-producing bacteria of the family pasteurellaceae
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
US6783764B1 (en) * 1997-04-10 2004-08-31 Akzo Nobel Nv Actinobacillus pleuropneumoniae subunit vaccine
CH692179A5 (de) 1997-06-25 2002-03-15 Kueschall Design Ag Rollstuhl und Sitzmodul für den Rollstuhl,
US20010018055A1 (en) * 1997-09-25 2001-08-30 Briggs Robert E. Deletion mutants of virulence factors of pasteurellaceae
US6790950B2 (en) * 1999-04-09 2004-09-14 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
WO2000061724A2 (en) * 1999-04-09 2000-10-19 Pharmacia & Upjohn Company Anti-bacterial vaccine compositions
GB9910812D0 (en) * 1999-05-10 1999-07-07 Microscience Ltd Vaccine composition
US6780405B1 (en) * 2000-04-28 2004-08-24 Avant Immunotherapeutics, Inc. Regulated antigen delivery system (RADS)
WO2002018601A2 (en) * 2000-08-25 2002-03-07 Abbott Laboratories Essential bacteria genes and genome scanning in haemophilus influenzae for the identification of 'essential genes'
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
EP1350796B1 (en) * 2002-04-05 2009-01-07 Merial Attenuated gram negative bacteria
US7449178B2 (en) 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
WO2004087749A2 (en) * 2003-03-27 2004-10-14 Children's Hospital, Inc. Nontypeable haemophilus influenzae virulence factors
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
TWI328458B (en) * 2007-03-09 2010-08-11 Univ Nat Chunghsing Subunit vaccine of pasteurella multocida in veterinary uses

Also Published As

Publication number Publication date
NZ535993A (en) 2010-02-26
US20040033586A1 (en) 2004-02-19
WO2003086277A9 (en) 2006-02-23
WO2003086277A2 (en) 2003-10-23
EP1575483B1 (en) 2011-08-03
HK1078271A1 (en) 2006-03-10
ES2371498T3 (es) 2012-01-03
CA2481186C (en) 2015-10-06
ATE518955T1 (de) 2011-08-15
KR101037566B1 (ko) 2011-05-27
US7943125B2 (en) 2011-05-17
CO5640065A1 (es) 2006-05-31
BRPI0309001B1 (pt) 2021-11-30
WO2003086277A3 (en) 2007-03-01
US20090252766A1 (en) 2009-10-08
EP1575483A4 (en) 2007-07-04
CA2481186A1 (en) 2003-10-23
US7449178B2 (en) 2008-11-11
US8329163B2 (en) 2012-12-11
MXPA04009730A (es) 2006-04-28
CN1934240A (zh) 2007-03-21
US20120009218A1 (en) 2012-01-12
AU2010206113A1 (en) 2010-08-26
BRPI0309001A2 (pt) 2017-07-04
KR20050016334A (ko) 2005-02-21
EP1575483A2 (en) 2005-09-21
CN102864090A (zh) 2013-01-09
AU2003223447B2 (en) 2010-06-03
JP2005535296A (ja) 2005-11-24
AU2010206113B2 (en) 2012-03-15
AU2003223447A1 (en) 2003-10-27
AU2003223447C1 (en) 2011-01-06
JP4338528B2 (ja) 2009-10-07

Similar Documents

Publication Publication Date Title
EP1575483A4 (en) GRAM NEGATIVE BACTERIA ATTENUATED
DE60310264D1 (en) Thermostabile alpha-amylase
GEP20032977B (en) Proteinase K-Resistant Surface Protein of Neisseria Meningitidis
WO2002062378A3 (en) Hyperblebbing bacterial strains and use thereof for production of vaccines
NZ549873A (en) Compounds and methods for treatment and diagnosis of chlamydial infection by stimulating an immune response
PT721506E (pt) Proteinas exportadas bacterianas e vacinas acelulares baseadas nestas
EP2455468A3 (en) Amylase variants
IL162917A0 (en) A lysin from bacteriophage and pharmaceutical compositions containing the same
ES2535961T3 (es) Bacteria pasteurelácea atenuada que tiene una mutación en un gen de virulencia
HU9801384D0 (en) Clostridium perfringeus vaccine
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
CY1108972T1 (el) Εξασθενημενα αρνητικα κατα gram βακτηρια
HU0004877D0 (pt)
BR9506038A (pt) Dna clonato vetor recombinante e planta
MX9603876A (es) Procedimiento intermitente de digestion para producir pulpa deslignficada.
KR930013104A (ko) 세르풀리나 하이오다이센테리애 백신
NZ511166A (en) Genes that increase the production of HMG-CoA reductase inhibitor, ML-236B
MXPA01010425A (es) Fragmentos de acido nucleico para la identificacion de bacterias descloradoras.
NO20025126L (no) (R)-2-hydroksy-3-fenylpropionisk syre (D-fenylmelkesyre) dehydrogenase, oggen som koder for samme
GB9027901D0 (en) Acellular vaccine
WO2000046242A3 (en) 19 KILODALTON PROTEIN OF $i(HELICOBACTER PYLORI)
AU2002212114A1 (en) Nucleotide sequences which code for the ccpa1 gene
AU2001227101A1 (en) Wt1-interacting protein wtip